Nicox S.A.

Nicox S.A.verified

NICXF

Price:

$0.3

Market Cap:

$24.60M

Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating prostaglandin analog for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in phase 3 clinical trial. The company is also developing NCX 4251, a proprietary formulation of fluticasone for acute exacerbations of blepharitis that is in a Phase 2b clinical trial for the treatment of acute exacerbations of blepharitis; and NCX 1728.It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle...[Read more]

Industry

Biotechnology

IPO Date

2010-02-22

Stock Exchange

OTC

Ticker

NICXF

The ROE as of December 2025 (TTM) for Nicox S.A. (NICXF) is -180.37%

According to Nicox S.A.’s latest financial reports and current stock price. The company's current ROE is -180.37%. This represents a change of 640.00% compared to the average of -24.37% of the last 4 quarters.

Nicox S.A. (NICXF) Historical ROE (quarterly & annually)

How has NICXF ROE performed in the past?

The mean historical ROE of Nicox S.A. over the last ten years is -150.56%. The current -180.37% ROE has changed 19.80% with respect to the historical average. Over the past ten years (40 quarters), NICXF's ROE was at its highest in in the June 2022 quarter at 0%. The ROE was at its lowest in in the December 2023 quarter at -97.48%.

Quarterly (TTM)
Annual

Average

-150.56%

Median

-65.95%

Minimum

-656.01%

Maximum

0%

Nicox S.A. (NICXF) ROE by Quarter and Year

Discovering the peaks and valleys of Nicox S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 572.72%

Maximum Annual ROE = 0%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -656.01%

Quarterly (TTM)
Annual
YearROEChange
2024-656.01%572.72%
2023-97.52%31.83%
2022-73.97%27.71%
2021-57.92%222.72%
2020-17.95%-Infinity%

Nicox S.A. (NICXF) Average ROE

How has NICXF ROE performed in the past?

The current ROE of Nicox S.A. (NICXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-275.83%

5-year avg

-180.67%

10-year avg

-150.56%

Nicox S.A. (NICXF) ROE vs. Peers

How is NICXF’s ROE compared to its peers?

Nicox S.A.’s ROE is greater than Alterity Therapeutics Limited (-48.41%), greater than Calliditas Therapeutics AB (publ) (-84.68%), less than BioStem Technologies, Inc. (65.93%), greater than IXICO plc (-14.21%), greater than Actinogen Medical Limited (-69.65%), greater than Relief Therapeutics Holding AG (-49.18%), greater than Relief Therapeutics Holding AG (-49.18%), greater than Planet 13 Holdings Inc. (-41.69%), less than Helix BioPharma Corp. (1.33%), greater than Imugene Limited (-127.46%),

Build a custom stock screener for Nicox S.A. (NICXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nicox S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nicox S.A. (NICXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nicox S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Nicox S.A.'s ROE?

How is the ROE calculated for Nicox S.A. (NICXF)?

What is the highest ROE for Nicox S.A. (NICXF)?

What is the 3-year average ROE for Nicox S.A. (NICXF)?

What is the 5-year average ROE for Nicox S.A. (NICXF)?

How does the current ROE for Nicox S.A. (NICXF) compare to its historical average?